# US 2005/0239737 A1 · Identification of molecular interaction sites in RNA for novel drug discovery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0239737 A1
- Document ID: US20050239737A1
- Status: Published application
- Kind: A1
- Application number: 11/146,468
- Filed: 2005-06-07
- Published: 2005-10-27
- Earliest claimed: 1998-05-12
- Assignees: Isis Pharmaceuticals, Inc.
- Inventors: David Ecker; Ranga Sampath; Richard Griffey; John McNeil
- Web page: https://patentgrep.com/patent/US20050239737A1

## CPC

- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- A61P 31/04: Antibacterial agents
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Methods of identifying molecular interaction sites in eukaryotic and prokaryotic nucleic acids, especially RNA, are described. Secondary structural elements are identified from highly conserved sequences. Methods of preparing databases relating to such molecular interaction sites are also provided herein as are databases themselves. Therapeutic, agricultural, industrial, and other applicability results from interaction of such molecular interaction sites with “small” and other molecules.

## Claims

### Claim 1

An isolated oligonucleotide comprising a molecular interaction site, wherein:
the molecular interaction site consists of less than 50 nucleotides;
the molecular interaction site is present in the RNA of a selected organism and in the RNA of at least one additional organism;
the molecular interaction site serves as a binding site for at least one molecule that when bound to the molecular interaction site modulates the expression of the RNA in the selected organism; and
the oligonucleotide does not comprise an iron response element or 3′ untranslated region of a histone mRNA.

### Claim 2 (depends on 1)

The oligonucleotide of claim 1 wherein the molecular interaction site consists of less than 30 nucleotides.

### Claim 3 (depends on 1)

The oligonucleotide of claim 1 wherein the molecular interaction site is present in the mRNA, pre-mRNA, tRNA, rRNA, or snRNA of a selected organism and in the mRNA, pre-mRNA, tRNA, rRNA, or snRNA of at least one additional organism.

### Claim 4 (depends on 3)

The oligonucleotide of claim 3 wherein the molecular interaction site is present in the mRNA of a selected organism and in the mRNA of at least one additional organism.

### Claim 5 (depends on 3)

The oligonucleotide of claim 3 wherein the molecular interaction site is present in the pre-mRNA of a selected organism and in the pre-mRNA of at least one additional organism.

### Claim 6 (depends on 3)

The oligonucleotide of claim 3 wherein the molecular interaction site is present in the tRNA of a selected organism and in the tRNA of at least one additional organism.

### Claim 7 (depends on 3)

The oligonucleotide of claim 3 wherein the molecular interaction site is present in the rRNA of a selected organism and in the rRNA of at least one additional organism.

### Claim 8 (depends on 3)

The oligonucleotide of claim 3 wherein the molecular interaction site is present in the snRNA of a selected organism and in the snRNA of at least one additional organism.

### Claim 9 (depends on 1)

The oligonucleotide of claim 1 wherein the molecular interaction site serves as a binding site for at least one oligomer molecule that when bound to the molecular interaction site modulates the expression of the RNA in the selected organism.

### Claim 10 (depends on 1)

The oligonucleotide of claim 1 wherein the molecular interaction site serves as a binding site for at least one oligonucleotide that when bound to the molecular interaction site modulates the expression of the RNA in the selected organism.

### Claim 11 (depends on 1)

The oligonucleotide of claim 1 wherein the molecular interaction site comprises at least one bulge, loop, stem, hairpin, knot, triple interact, cloverleaf, or helix.

### Claim 12 (depends on 1)

The oligonucleotide of claim 1 wherein the molecular interaction site comprises at least one hairpin.

### Claim 13 (depends on 1)

The oligonucleotide of claim 1 wherein the oligonucleotide consists of the molecular interaction site.

### Claim 14 (depends on 1)

The oligonucleotide of claim 1 wherein the selected organism and additional organism are prokaryotes.

### Claim 15 (depends on 1)

The oligonucleotide of claim 1 wherein the selected organism and additional organism are eukaryotes.

### Claim 16 (depends on 1)

A duplex comprising an oligonucleotide of claim 1 and an oligomer molecule.

### Claim 17 (depends on 1)

A duplex comprising an oligonucleotide of claim 1 and an oligonucleotide hybridized thereto.

### Claim 18 (depends on 1)

A composition comprising an oligonucleotide of claim 1.
